Antibacterial coatings are materials that reduce implants related infections in patients by inhibiting bacterial adhesion, colonization, and proliferation of bacteria on the implant surface and into the surrounding tissues. Medical implants are highly susceptible to infection and may result to risk in surgery. Therefore, treatment with antibacterial coatings provide protection against pathologically relevant strains of bacteria.
The global antimicrobial coatings market for medical implants was $120.22 million in 2016, and is projected to reach $343.16 million by 2023, registering a CAGR of 16.1% from 2017 to 2023. Rise in prevalence of implant associated infections, technological advancements in antibacterial coatings, and high adoption of cardiovascular & orthopedics implants drive the market growth. Moreover, increase in geriatric population and rise in burden of bone related disorders and cardiovascular diseases across the globe further drives the market growth. However, time-consuming regulatory approval process and high cost of coating impedes the market growth. Conversely, increase in awareness about implantation surgeries, development of effective antibacterial coating for medical implants, and rise in demand for better healthcare facilities are expected to provide opportunities for the market growth during the forecast period.
The global antibacterial coating market for medical implants is segmented based on material, type, and region. Based on material, it is bifurcated into metallic and non-metallic coatings. Metallic coatings are further segmented into silver coatings, copper coatings, and other coatings.
Non-metallic coatings segment is further divided into polymeric coatings and organic coatings. Based on type, the market is divided into orthopedic, dental, neurovascular, cardiac, and other implants. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
Key Market Segments
Key players profiled in the report:
Cephalosporin Market by Generation (First-generation, Second-generation, Third-generation, Fourth-generation, and Fifth-generation), Type (Branded and Generics), Route of Drug Administration (Injection and Oral), and Application (Respiratory Tract Infection, Skin Infection, Ear Infection, Urinary Tract Infection, and Sexually Transmitted Infection) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. It resembles penicillin and hence is used as an alternative for patients who are allergic to penicillin. It is used in the treatment of a variety of clinical conditions, including pneumonia, skin infections, strep ...
November 2017 | $5370 |View Details>>
The Global Drugs for Malaria market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Drugs for Malaria market, especially in North America, Europe, Asia-Pacific, South ...
November 2017 | $4960 |View Details>>
In 2016, the Asia-Pacific Drugs for Malaria market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Drugs for Malaria in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, India, Australia, Indonesia, Thailand and ...
November 2017 | $4660 |View Details>>
In 2016, the Drugs for Malaria market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include Cipla Guilin Pharmaceutical ...
November 2017 | $3360 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research